He Xiao

机构：Central South University, National Clinical Research Center for Digestive Diseases, National Engineering Research Center of Human Stem Cells, First Affiliated Hospital of Gannan Medical University, Xiangya Hospital Central South University, Tsinghua University · ORCID：0000-0003-2298-1121

发表论文 56 篇 · 总被引 378 次 · h-index 12

代表论文

• Clinical significance of interleukin‑10 concentration in the cerebrospinal fluid of patients with primary central nervous system lymphoma (2020 · Oncology Letters · 被引 26)
• APE1 may influence CD4+ naïve T cells on recurrence free survival in early stage NSCLC (2021 · BMC Cancer · 被引 17)
• Microenvironment-triggered copper peroxide and tannic acid cooperatively iron-coordinated nanocomposites for oxidative stress-enhanced radiotherapy of hepatocellular carcinoma (2025 · Nano Today · 被引 10)
• Identification of low-density lipoprotein receptor class A domain containing 4 (LDLRAD4) as a prognostic indicator in primary gastrointestinal stromal tumors (2020 · Current Problems in Cancer · 被引 10)
• A novel immune-related microRNA signature for prognosis of thymoma (2022 · Aging · 被引 9)
• Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors (2022 · Thoracic Cancer · 被引 6)